Submission for OMB Review; Comment Request, 8461-8462 [2014-02949]
Download as PDF
<![CDATA[
8461
Federal Register / Vol. 79, No. 29 / Wednesday, February 12, 2014 / Notices
both the adult and pediatric groups.
There are no costs to respondents. The
total response burden for the study 201
hours.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent
Number of
respondents
Average
burden per
response
(in hours)
Type of respondents (adult and pediatric)
Form name
Case Subjects > 17 years of age ...................
Screening Process .........................................
Telephone interview .......................................
Screening Process .........................................
Telephone interview .......................................
Screening Process .........................................
Telephone interview .......................................
Screening Process .........................................
Telephone interview .......................................
129
71
142
71
141
78
194
78
1
1
1
1
1
1
1
1
5/60
30/60
5/60
30/60
5/60
30/60
5/60
30/60
.........................................................................
........................
........................
........................
Control Subjects > 17 years of age ................
Case Subject ≤ 1–5 years of age ...................
Control Subjects ≤ 1–5 years of age ..............
Total .........................................................
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2014–03013 Filed 2–11–14; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Submission for OMB Review;
Comment Request
Title: Head Start Family and Child
Experiences Survey (FACES)
OMB No.: 0970–0151
Description: The Office of Planning,
Research and Evaluation (OPRE),
Administration for Children and
Families (ACF), U.S. Department of
Health and Human Services (HHS), is
proposing to collect data for a new
round of the Head Start Family and
Child Experiences Survey (FACES).
Featuring a new ‘‘Core Plus’’ study
design, FACES will provide data on a
set of key indicators, including
information for performance measures.
The design allows for more rapid and
frequent data reporting (Core studies)
and serves as a vehicle for studying
more complex issues and topics in
greater detail and with increased
efficiency (Plus studies).
In fall 2014 and spring 2015, the
FACES Core study will assess the school
readiness skills of Head Start children,
survey their parents, and ask their Head
Start teachers to rate children’s social
and emotional skills. In spring 2015 and
again in spring 2017, the number of
programs in the FACES Core study
sample will increase from the 60 that
are used to collect data on children’s
school readiness outcomes to 180 for the
purpose of conducting observations in
720 Head Start classrooms. Program
director, center director, and teacher
surveys will also be conducted at these
time points. FACES Plus studies include
additional survey content of policy or
programmatic interest, and may involve
more programs being sampled. This
notice is specific to the data collection
activities needed to recruit Head Start
programs and centers into FACES. A
future notice will provide information
about data collection for the Core and
Plus studies.
The method of data collection for
recruitment of all programs (180 for the
FACES Core and up to 50 additional
programs for FACES Plus studies) will
include telephone conversations with
program directors and on-site
coordinators who serve as liaisons
between the FACES study team and the
Head Start centers. These calls will
inform program staff about the purpose
of the study and will be used to identify
the number of centers in each program
in order to compile the center sampling
frame.
The purpose of this data collection is
to support the 2007 reauthorization of
the Head Start program (Pub.L. 110–
134), which calls for periodic
assessments of Head Start’s quality and
effectiveness.
Respondents: Head Start Program
Directors and Staff.
ANNUAL BURDEN ESTIMATES
Total number
of respondents
Instrument
Annual
number of
respondents
Number of
responses per
respondent
Average
burden hour
per response
Estimated
annual
burden hours
230
230
77
77
2
2
1
.75
154
116
Total ............................................................................
mstockstill on DSK4VPTVN1PROD with NOTICES
Telephone script for program directors .............................
Telephone script for on-site coordinators ..........................
........................
........................
........................
..........................
270
Additional Information: Copies of the
proposed collection may be obtained by
writing to the Administration for
Children and Families, Office of
Planning, Research and Evaluation, 370
L’Enfant Promenade SW., Washington,
DC 20447, Attn: OPRE Reports
VerDate Mar<15>2010
17:11 Feb 11, 2014
Jkt 232001
Clearance Officer. All requests should
be identified by the title of the
information collection. Email address:
OPREinfocollection@acf.hhs.gov.
OMB Comment: OMB is required to
make a decision concerning the
collection of information between 30
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
and 60 days after publication of this
document in the Federal Register.
Therefore, a comment is best assured of
having its full effect if OMB receives it
within 30 days of publication. Written
comments and recommendations for the
proposed information collection should
E:\FR\FM\12FEN1.SGM
12FEN1
8462
Federal Register / Vol. 79, No. 29 / Wednesday, February 12, 2014 / Notices
be sent directly to the following: Office
of Management and Budget, Paperwork
Reduction Project, Fax: 202–395–6974,
Attn: Desk Officer for the
Administration for Children and
Families.
Karl Koerper
OPRE Reports Clearance Officer.
[FR Doc. 2014–02949 Filed 2–11–14; 8:45 am]
BILLING CODE 4184–22–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2014–N–0001]
Synergizing Efforts in Standards
Development for Cellular Therapies
and Regenerative Medicine Products;
Public Workshop
AGENCY:
Food and Drug Administration,
HHS.
mstockstill on DSK4VPTVN1PROD with NOTICES
ACTION:
Notice of public workshop.
The Food and Drug Administration
(FDA), Center for Biologics Evaluation
and Research (CBER), is announcing a
public workshop entitled ‘‘Synergizing
Efforts in Standards Development for
Cellular Therapies and Regenerative
Medicine Products.’’ The purpose of the
public workshop is to bring together a
broad range of stakeholders to discuss
current and future standards
development activities involving
cellular therapies and regenerative
medicine products. This public
workshop is being rescheduled due to
the government shutdown.
Date and Time: The public workshop
will be held on March 31, 2014, from
8:30 a.m. to 4:30 p.m.
Location: The public workshop will
be held at the FDA White Oak Campus,
10903 New Hampshire Ave., Bldg. 31
Conference Center, the Great Room (Rm.
1503 A), Silver Spring, MD 20993–0002.
Entrance for the public workshop
participants (non-FDA employees) is
through Building 1 where routine
security check procedures will be
performed. Please visit the following
Web site for location, parking, security,
and travel information: https://www.fda.
gov/AboutFDA/WorkingatFDA/
BuildingsandFacilities/WhiteOak
CampusInformation/ucm241740.htm.
Contact Person: Sherri Revell, Center
for Biologics Evaluation and Research
(HFM–49), Food and Drug
Administration, 1401 Rockville Pike,
Suite 200N, Rockville, MD 20852–1448,
301–827–2000, FAX: 301–827–3079,
email: CBERPublicEvents@fda.hhs.gov
(Subject line: SESDCTRMP Workshop).
VerDate Mar<15>2010
17:11 Feb 11, 2014
Jkt 232001
Registration: Mail or fax your
registration information (including
name, title, firm name, address,
telephone, and fax numbers) to Sherri
Revell (see Contact Person) or email to
CBERPublicEvents@fda.hhs.gov (Subject
line: SESDCTRMP Workshop
Registration) by March 24, 2014. There
is no registration fee for the public
workshop. Early registration is
recommended because seating is
limited. Registration on the day of the
public workshop will be provided on a
space available basis beginning at 7:30
a.m.
Streaming Webcast of the Public
Workshop: For those unable to attend in
person, FDA will Webcast the public
workshop. To join the Webcast of the
public workshop, please go to: https://
collaboration.fda.gov/
sesdctrmpworkshop/. If you have never
attended an Adobe Connect meeting
before, test your connection at https://
collaboration.fda.gov/common/help/en/
support/meeting_test.htm. Get a quick
overview: https://www.adobe.com/go/
connectpro_overview. Registration is not
required for those attending via Adobe
Connect.
If you need special accommodations
due to a disability, please contact Sherri
Revell (see Contact Person) at least 7
days in advance.
SUPPLEMENTARY INFORMATION:
Standardization efforts concerning the
clinical development of cellular
therapies and regenerative medicine
products have generated a great deal of
interest. These efforts include standards
development, expert opinion position
papers, and professional practice
guidelines. However, relatively little is
done to coordinate the various existing
efforts. In the public workshop, FDA
hopes to bring together a broad range of
stakeholders of cellular therapies and
regenerative medicine products in order
to:
• Inform stakeholders about the types
of standards and standards
organizations that are available
currently, the role that the Federal
Agencies play in standards
development, and the potential role that
stakeholders can play in standards
development.
• Provide a high-level overview of
current standards development
activities in the fields of cellular therapy
and regenerative medicine and the
regulatory application of standards.
• Provide opportunity for discussion
of areas of high interest for current or
future standards development in the
fields of cellular therapy and
regenerative medicine and to explore
ways to minimize redundancy and
maximize collaboration.
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
We encourage all who have an
interest in the development of cellular
therapies and regenerative medicine
products to attend the public workshop.
This public workshop is being
rescheduled due to the government
shutdown. It was originally scheduled
for October 7, 2013 (see 78 FR 43889,
July 22, 2013). Those who registered for
the original workshop date must register
again for the rescheduled date (see
Registration).
Transcripts: Please be advised that as
soon as possible after a transcript of the
public workshop is available, it will be
accessible at: https://www.fda.gov/
BiologicsBloodVaccines/NewsEvents/
WorkshopsMeetingsConferences/
TranscriptsMinutes/default.htm.
Transcripts of the public workshop may
also be requested in writing from the
Division of Freedom of Information
(ELEM–1029), Food and Drug
Administration, 12420 Parklawn Dr.,
Element Bldg., Rockville, MD 20857.
Dated: February 6, 2014.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2014–03015 Filed 2–11–14; 8:45 am]
BILLING CODE 4160–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2014–N–0001]
Anti-Infective Drugs Advisory
Committee; Notice of Meeting
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
This notice announces a forthcoming
meeting of a public advisory committee
of the Food and Drug Administration
(FDA). The meeting will be open to the
public.
Name of Committee: Anti-Infective
Drugs Advisory Committee.
General Function of the Committee:
To provide advice and
recommendations to the Agency on
FDA’s regulatory issues.
Date and Time: The meeting will be
held on March 31, 2014, from 8 a.m. to
5 p.m.
Location: FDA White Oak Campus,
10903 New Hampshire Ave., Bldg. 31
Conference Center, the Great Room (rm.
1503), Silver Spring, MD 20993–0002.
Information regarding special
accommodations due to a disability,
visitor parking, and transportation may
be accessed at: https://www.fda.gov/
AdvisoryCommittees/default.htm; under
E:\FR\FM\12FEN1.SGM
12FEN1
]]>Agencies
[Federal Register Volume 79, Number 29 (Wednesday, February 12, 2014)]
[Notices]
[Pages 8461-8462]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-02949]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration for Children and Families
Submission for OMB Review; Comment Request
Title: Head Start Family and Child Experiences Survey (FACES)
OMB No.: 0970-0151
Description: The Office of Planning, Research and Evaluation
(OPRE), Administration for Children and Families (ACF), U.S. Department
of Health and Human Services (HHS), is proposing to collect data for a
new round of the Head Start Family and Child Experiences Survey
(FACES). Featuring a new ``Core Plus'' study design, FACES will provide
data on a set of key indicators, including information for performance
measures. The design allows for more rapid and frequent data reporting
(Core studies) and serves as a vehicle for studying more complex issues
and topics in greater detail and with increased efficiency (Plus
studies).
In fall 2014 and spring 2015, the FACES Core study will assess the
school readiness skills of Head Start children, survey their parents,
and ask their Head Start teachers to rate children's social and
emotional skills. In spring 2015 and again in spring 2017, the number
of programs in the FACES Core study sample will increase from the 60
that are used to collect data on children's school readiness outcomes
to 180 for the purpose of conducting observations in 720 Head Start
classrooms. Program director, center director, and teacher surveys will
also be conducted at these time points. FACES Plus studies include
additional survey content of policy or programmatic interest, and may
involve more programs being sampled. This notice is specific to the
data collection activities needed to recruit Head Start programs and
centers into FACES. A future notice will provide information about data
collection for the Core and Plus studies.
The method of data collection for recruitment of all programs (180
for the FACES Core and up to 50 additional programs for FACES Plus
studies) will include telephone conversations with program directors
and on-site coordinators who serve as liaisons between the FACES study
team and the Head Start centers. These calls will inform program staff
about the purpose of the study and will be used to identify the number
of centers in each program in order to compile the center sampling
frame.
The purpose of this data collection is to support the 2007
reauthorization of the Head Start program (Pub.L. 110-134), which calls
for periodic assessments of Head Start's quality and effectiveness.
Respondents: Head Start Program Directors and Staff.
Annual Burden Estimates
----------------------------------------------------------------------------------------------------------------
Number of Average burden Estimated
Instrument Total number Annual number responses per hour per annual burden
of respondents of respondents respondent response hours
----------------------------------------------------------------------------------------------------------------
Telephone script for program 230 77 2 1 154
directors......................
Telephone script for on-site 230 77 2 .75 116
coordinators...................
-------------------------------------------------------------------------------
Total....................... .............. .............. .............. .............. 270
----------------------------------------------------------------------------------------------------------------
Additional Information: Copies of the proposed collection may be
obtained by writing to the Administration for Children and Families,
Office of Planning, Research and Evaluation, 370 L'Enfant Promenade
SW., Washington, DC 20447, Attn: OPRE Reports Clearance Officer. All
requests should be identified by the title of the information
collection. Email address: OPREinfocollection@acf.hhs.gov.
OMB Comment: OMB is required to make a decision concerning the
collection of information between 30 and 60 days after publication of
this document in the Federal Register. Therefore, a comment is best
assured of having its full effect if OMB receives it within 30 days of
publication. Written comments and recommendations for the proposed
information collection should
[[Page 8462]]
be sent directly to the following: Office of Management and Budget,
Paperwork Reduction Project, Fax: 202-395-6974, Attn: Desk Officer for
the Administration for Children and Families.
Karl Koerper
OPRE Reports Clearance Officer.
[FR Doc. 2014-02949 Filed 2-11-14; 8:45 am]
BILLING CODE 4184-22-P
